科济药业-B(02171)11月6日斥资2630.78万港元回购173.4万股

Core Viewpoint - Kintor Pharmaceutical Co., Ltd. announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company plans to repurchase 1.734 million shares at a total cost of HKD 26.3078 million [1] - The buyback is scheduled for November 6, 2025, reflecting a strategic move to enhance shareholder value [1]